<DOC>
	<DOCNO>NCT01351129</DOCNO>
	<brief_summary>The primary purpose study evaluate pharmacokinetics , safety tolerability three different formulation PF-04991532 healthy adult subject .</brief_summary>
	<brief_title>Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female ( nonchildbearing potential ) subject age 21 55 year , inclusive . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . An informed consent document sign date subject . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) disease clinical finding Screening . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>formulation comparison</keyword>
</DOC>